Cramer: Mea culpa! This stock's action is why I say small-cap biotechs are only for speculation

Jim Cramer admits he was too eager about the stock of Alder BioPharmaceuticals, which just took a huge hit.
Source: CNBC

Leave a Reply

Your email address will not be published.

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>